PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22743615-4 2012 Using a tetracycline-regulated inducible expression system, we unveiled functional roles of LTBP-2 in suppressing colony formation, anchorage-independent growth, cell migration, angiogenesis, VEGF secretion, and tumorigenicity. Tetracycline 8-20 vascular endothelial growth factor A Homo sapiens 192-196 18333801-3 2008 Moreover, to regulate overexpression of isoform 165 of VEGF and its effect on healing, we introduced a tetracycline (TC)-inducible gene switch in the expression plasmid. Tetracycline 103-115 vascular endothelial growth factor A Homo sapiens 55-59 18333801-3 2008 Moreover, to regulate overexpression of isoform 165 of VEGF and its effect on healing, we introduced a tetracycline (TC)-inducible gene switch in the expression plasmid. Tetracycline 117-119 vascular endothelial growth factor A Homo sapiens 55-59 16242193-8 2006 CONCLUSIONS: Tetracycline derivatives may have therapeutic effects on the pathologic remodellation of advanced human aortic stenosis through the inhibition of MMP-9 and VEGF production. Tetracycline 13-25 vascular endothelial growth factor A Homo sapiens 169-173 15289334-5 2004 We demonstrate here that in EJ human bladder cancer cells containing a tetracycline-regulatable s-HB-EGF or pro-HB-EGF expression system, s-HB-EGF expression increased their transformed phenotypes, including growth rate, colony-forming ability, and activation of cyclin D1 promoter, as well as induction of vascular endothelial growth factor in vitro. Tetracycline 71-83 vascular endothelial growth factor A Homo sapiens 307-341 11880187-1 2002 Previously, we demonstrated the significance of vascular endothelial growth factor (VEGF) in promoting the growth of tetracycline-regulated human VEGF165 retroviral vector transduced T47-D breast carcinoma cells, particularly at the early stages of tumor development (Cancer Res. Tetracycline 117-129 vascular endothelial growth factor A Homo sapiens 48-82 11880187-1 2002 Previously, we demonstrated the significance of vascular endothelial growth factor (VEGF) in promoting the growth of tetracycline-regulated human VEGF165 retroviral vector transduced T47-D breast carcinoma cells, particularly at the early stages of tumor development (Cancer Res. Tetracycline 117-129 vascular endothelial growth factor A Homo sapiens 84-88 10485491-5 1999 By delivering the VEGF gene within the self-contained tetracycline-regulated retroviral vector (Retro-Tet) into hepatocellular carcinoma (HCC) cells, we manipulated VEGF expression by providing tetracycline in the drinking water to assess the tumor kinetics mediated exclusively by VEGF. Tetracycline 54-66 vascular endothelial growth factor A Homo sapiens 18-22 10485491-5 1999 By delivering the VEGF gene within the self-contained tetracycline-regulated retroviral vector (Retro-Tet) into hepatocellular carcinoma (HCC) cells, we manipulated VEGF expression by providing tetracycline in the drinking water to assess the tumor kinetics mediated exclusively by VEGF. Tetracycline 54-66 vascular endothelial growth factor A Homo sapiens 165-169 10485491-5 1999 By delivering the VEGF gene within the self-contained tetracycline-regulated retroviral vector (Retro-Tet) into hepatocellular carcinoma (HCC) cells, we manipulated VEGF expression by providing tetracycline in the drinking water to assess the tumor kinetics mediated exclusively by VEGF. Tetracycline 54-66 vascular endothelial growth factor A Homo sapiens 165-169 10485491-5 1999 By delivering the VEGF gene within the self-contained tetracycline-regulated retroviral vector (Retro-Tet) into hepatocellular carcinoma (HCC) cells, we manipulated VEGF expression by providing tetracycline in the drinking water to assess the tumor kinetics mediated exclusively by VEGF. Tetracycline 194-206 vascular endothelial growth factor A Homo sapiens 18-22 10485491-5 1999 By delivering the VEGF gene within the self-contained tetracycline-regulated retroviral vector (Retro-Tet) into hepatocellular carcinoma (HCC) cells, we manipulated VEGF expression by providing tetracycline in the drinking water to assess the tumor kinetics mediated exclusively by VEGF. Tetracycline 194-206 vascular endothelial growth factor A Homo sapiens 165-169 10485491-5 1999 By delivering the VEGF gene within the self-contained tetracycline-regulated retroviral vector (Retro-Tet) into hepatocellular carcinoma (HCC) cells, we manipulated VEGF expression by providing tetracycline in the drinking water to assess the tumor kinetics mediated exclusively by VEGF. Tetracycline 194-206 vascular endothelial growth factor A Homo sapiens 165-169 9916127-4 1999 In a xenografted glioma, the selective vulnerability of immature vessels to VEGF loss was demonstrated by downregulating VEGF transgene expression using a tetracycline-regulated expression system. Tetracycline 155-167 vascular endothelial growth factor A Homo sapiens 76-80 9916127-4 1999 In a xenografted glioma, the selective vulnerability of immature vessels to VEGF loss was demonstrated by downregulating VEGF transgene expression using a tetracycline-regulated expression system. Tetracycline 155-167 vascular endothelial growth factor A Homo sapiens 121-125 9307273-1 1997 In this study, we used a self-contained tetracycline-regulated retroviral vector system to elucidate the role of vascular endothelial growth factor (VEGF) in controlling s.c. growth of human T-47D breast carcinoma cells. Tetracycline 40-52 vascular endothelial growth factor A Homo sapiens 113-147 9307273-1 1997 In this study, we used a self-contained tetracycline-regulated retroviral vector system to elucidate the role of vascular endothelial growth factor (VEGF) in controlling s.c. growth of human T-47D breast carcinoma cells. Tetracycline 40-52 vascular endothelial growth factor A Homo sapiens 149-153 9238051-3 1997 Using a tetracycline-regulated VEGF expression system in xenografted C6 glioma cells, we showed that shutting off VEGF production leads to detachment of endothelial cells from the walls of preformed vessels and their subsequent death by apoptosis. Tetracycline 8-20 vascular endothelial growth factor A Homo sapiens 31-35 9238051-3 1997 Using a tetracycline-regulated VEGF expression system in xenografted C6 glioma cells, we showed that shutting off VEGF production leads to detachment of endothelial cells from the walls of preformed vessels and their subsequent death by apoptosis. Tetracycline 8-20 vascular endothelial growth factor A Homo sapiens 114-118 31285943-11 2019 Furthermore, the cells grown with tetracycline-treated titanium disks showed significantly lower VEGF production than those in the SA group. Tetracycline 34-46 vascular endothelial growth factor A Homo sapiens 97-101